$315k
4.12k
0.00%
$55.9
Polen Capital acquired 4.12k Dianthus Therapeutics shares worth $315k. That's 0.00% of their equity portfolio (193rd largest holding). The stake costed the investor $230k, netting the investor a gain of 37% so far.
Easily embed the chart on your blog or website – it will always update automatically!
To improve your user experience we use cookies. Privacy Policy
Necessary for the website to function.
Help us understand how you use our site.
Used to show relevant ads.